FDA formalizes one pivotal trial policy via NEJM perspective / Endpoints

Zachary Brennan / endpoints - Top FDA officials said that a single pivotal trial requirement will be the “new default standard” for drug approvals, a move that goes beyond the agency’s prior discretion around not requiring two trials. In a ...

#healthcare #pharmaceuticals #publichealth #governmentpolicy #biotech #drugdevelopment #fda

FDA formalizes one pivotal trial policy via NEJM perspective

19 days / endpoints / Zachary Brennan

FDA to drop 2-study requirement, expand OTC access

20 days / beckershospitalreview / Ella Jeffries

FDA will drop two-study requirement for new drug approvals, aiming to speed access

20 days / medicalxpress

Thursday, February 19, 2026, 11:24 am / permalink 19422 / 3 stories in 19 days

Nevada Debuts Public Option Amid Tumultuous Federal Changes to Health Care / Kaiser

Jazmin Orozco Rodriguez / kffhealthnews - The state recently became the third to offer a public option health plan through its Affordable Care Act marketplace. But researchers said it’s unlikely to fill the gaps left by sweeping changes at the federal level.

#healthcare #publichealth #governmentpolicy

When It Comes to Health Insurance, Federal Dollars Support More Than ACA Plans

19 days / kffhealthnews / Julie Appleby, KFF Health News

Study finds Medicaid disenrollment spikes at age 19, with rates up to 83.9%

20 days / medicalxpress

Nevada Debuts Public Option Amid Tumultuous Federal Changes to Health Care

20 days / kffhealthnews / Jazmin Orozco Rodriguez

Shorter may be sweeter: Study finds 15-second health ads can curb junk food cravings

21 days / medicalxpress

State public-option health plans expand but can't fill gaps left by federal changes

21 days / npr / Jazmin Orozco Rodriguez

Thursday, February 19, 2026, 5:22 am / permalink 19405 / 5 stories in 20 days

GOVERNMENTPOLICY Heatmap

90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.

More Top Stories...

FDA refuses to review Moderna mRNA flu vaccine application

Moderna’s mRNA flu vaccine application has been rejected by the FDA—Moderna received a refusal‐to‐file letter while accusing the agency of shifting its review standards. Multiple reports echo this regulatory setback, fueling industry concerns over consistent, transparent decision‐making. More...

FDA CRL halts AstraZeneca’s Saphnelo prefilled pen approval

AstraZeneca’s application to market its subcutaneous prefilled pen formulation of Saphnelo for treating lupus has hit a roadblock after the FDA issued a complete response letter. The decision delays the drug’s approval and raises questions about its future in the competitive immunotherapy market. More...

CMS proposes sweeping changes to ACA marketplace plan rules

CMS has proposed a major rule reshaping Affordable Care Act marketplace policies, including loosening limits on non-standard plan designs and promoting lower-premium options such as catastrophic coverage. The agency says the changes will reduce costs and boost flexibility, while critics warn they could increase confusion and weaken consumer protections—because shopping for insurance clearly wasn’t complicated enough. More...

Tenet forecasts major ACA exchange enrollment drop and financial hit

Tenet Healthcare is warning that the expiration of enhanced Affordable Care Act premium tax credits will drive a steep reduction in ACA exchange enrollment, projecting a significant revenue impact in 2026. Despite the headwind, the company says it expects earnings growth, leaning on acuity and operational performance—because nothing calms Wall Street like “we’ll make it up somewhere else.” More...

City of Hope promotes Nisha Morris to senior marketing chief

City of Hope named Nisha Morris as Senior Vice President and Chief Marketing and Communications Officer, adding marketing leadership to its executive team. The move signals a renewed focus on brand, outreach, and patient engagement as the cancer center sharpens its communication and growth strategies. More...